Organic sales grew 2.1% in H1 2026, with Q2 accelerating to 8.5% growth, driven by volume/mix gains. Adjusted EBITDA margin declined to 14.1% in H1, and FY 2026 margin guidance was lowered to above 16%. Free cash flow guidance and sales growth outlook were maintained.Original document: Corbion NV…
Organic sales grew 2.1% in H1 2026, with Q2 accelerating to 8.5% growth, driven by volume/mix gains. Adjusted EBITDA margin declined to 14.1% in H1, and FY 2026 margin guidance was lowered to above 16%. Free cash flow guidance and sales growth outlook were maintained.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
